Key result
~58% of women discontinue postpartum antihypertensives, with baseline hypertension and eclampsia linked to lower discontinuation risk.
Why the study?
Hypertension is common during and after pregnancy, but patterns of antihypertensive medication discontinuation in the postpartum period are not well characterized.
Cohort (n=63,312)
Yes
More than half of postpartum women who initiate antihypertensive medication discontinue it, highlighting significant demographic and clinical disparities that may benefit from targeted follow-up.
Answers are grounded in this paper and cite their sources.
High postpartum antihypertensive discontinuation rates signal need for closer monitoring; leaves open optimal retention strategies in at-risk groups.
Background Hypertension is common during and after pregnancy. Patterns of antihypertensive medication discontinuation (AMD) in the postpartum period are not well characterized. This study examined factors associated with AMD among postpartum women. Methods A retrospective claims analysis was conducted using the Komodo Health Healthcare Map. The study included 63,312 postpartum women aged 18-64 years who delivered between January 1, 2019, and December 31, 2022, and initiated an antihypertensive medication within 30 days after live delivery. AMD was defined as the absence of any anti-hypertensive medication from index medication (days’ supply + 30-day). Multivariable Poisson regression models with a log link and robust variance estimators were used. Results Discontinuation occurred in 57.8% (36,576) of women. In adjusted analyses, older age was associated with lower risk of AMD compared with women aged 18-24 years (RR 0.93, 95% CI 0.93, 0.94 for ages 25-34; RR 0.89, 95% CI 0.88, 0.90 for ages 35-44; RR 0.85, 95% CI 0.82, 0.88 for ages ≥45). Hispanic (RR 1.03, 95% CI 1.02, 1.04) and Asian (RR 1.02, 95% CI 1.01, 1.04) women had higher risk of discontinuation compared with White women. Women with eclampsia (RR 0.97, 95% CI 0.97, 0.98), baseline hypertension (RR 0.95, 95% CI 0.95, 0.96), and postpartum depression (RR 0.95, 95% CI 0.94, 0.96) had lower risk of discontinuation. Conclusions Postpartum AMD was common in this national claims-based cohort. Differences across demographic and clinical subgroups highlight patient populations that may benefit from directed postpartum blood pressure follow-up and medication management.
No takes yet. Share an insight, caveat, or question.
Swart et al. (2026) conducted a cohort in Postpartum hypertension (n=63,312). Antihypertensive medication was evaluated on Antihypertensive medication discontinuation. Postpartum antihypertensive medication discontinuation occurred in 57.8% of women, with older age, eclampsia, baseline hypertension, and postpartum depression associated with lower risk.
Synapse has enriched 10 related papers. Consider them for comparative context: